Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®

Biosimilars are biological products that are highly similar to existing products approved by health authorities. Demonstration of similarity starts with the comprehensive analysis of the reference product and its proposed biosimilar at the physicochemical and functional levels. Here, we report the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnenat, Laurent, Palmese, Angelo, Fremaux, Christèle, D'Amici, Fabio, Terlizzese, Mariagrazia, Rossi, Mara, Chevalet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240642/
https://www.ncbi.nlm.nih.gov/pubmed/27854156
http://dx.doi.org/10.1080/19420862.2016.1259046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240642/
https://www.ncbi.nlm.nih.gov/pubmed/27854156
http://dx.doi.org/10.1080/19420862.2016.1259046

Ejemplares similares